top of page

GreenTech Investment Holdings Ltd (‘GTIH’) is a UK based bio-pharmaceutical company whose founders have been leaders in the drug development, targeted drug delivery and bio-pharmaceutical community for over 30+ years.   From leading companies such as Pfizer, Novo Nordisk, Upjohn and the World Bank, with R&D pedigrees from acclaimed universities from around the globe, GreenTech plans on becoming a beacon for botanically derived API's loaded into innovative products where our ADDS's improve drug and bio-active delivery performances. By targeting significant disease areas of unmet need with novel candidates, while generating short term revenues through our advanced generic and wellness product portfolio, we believe GreenTech is destined impact the bio-pharmaceutical landscape.  With positioning in the USA, Denmark, the UAE (Abu Dhabi) and South Africa, our novel formulations and patented drug delivery platforms are able to significantly outperform current standards of care (SoC) regimens thereby improving patient care.  Our team of KOL's and globally acclaimed clinical working group plan on targeting pain, wound care and longevity as our targeted areas of speciality.  Our products (OTC & Rx) will undergo international, multi-centre randomised control trials and will be produced in strategic locations where we have pre-established new drug (IND / IMP) development structures and our own IP protected manufacturing facilities. 

In the areas of wellness and longevity our ADDS's ensure a significant advantage over cosmeceutical competitors, while we create revenues for the intended block-buster novel programs.

 

Our management and founding team are composed of researchers and sector professionals who collectively have decades of experience in the areas of formulation & delivery science, therapeutics, genomics, R&D and of course, novel drug development. We believe our team comprises some of the finest talent in the pharmaceutical and neuroscience community today.  Innovation, expertise and a commitment to wellbeing is incorporated in the ethos and the intricate fabric of our business, while  disruptive thinking are the drivers behind the strategies that define GreenTech.

we are 

different

Longevity 1_edited.jpg
Advanced Drug Delivery (ADDS)
Gradient

© 2021 GreenTech Investment Holdings Ltd.

  • Black Facebook Icon
  • Black Twitter Icon
  • Black Instagram Icon
bottom of page